Angelini Pharma SpA - Company Profile
Powered by 
All the sales intelligence you need on Angelini Pharma SpA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Angelini Pharma SpA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Angelini Pharma SpA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Angelini Pharma SpA patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| GEP20227437B | Grant | 1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS | A61K31/4155; A61K31/4439; A61K31/496; A61K31/5377; A61P19/10; A61P25/00; A61P29/00; A61P3/10; A61P35/00; C07D405/12; C07D405/14; C07D409/12; C07D409/14 | November 10, 2022 |
| US20220331312A1 | Application | PEDIATRIC TRAZODONE COMPOSITIONS AND METHOD OF TREATMENT THEREOF | A61K31/497; A61K9/0053; A61K9/0095; A61P25/20 | October 20, 2022 |
| US20220296489A1 | Application | PEPTIDES HAVING INHIBITORY ACTIVITY ON NEURONAL EXOCYTOSIS | A61K38/00; A61K8/64; A61Q19/08; C07K7/06; C07K7/08 | September 22, 2022 |
| EP4034117A1 | Application | PÄDIATRISCHE TRAZODON-ZUSAMMENSETZUNGEN UND VERFAHREN ZU IHRER BEHANDLUNG | A61K2300/00; A61K31/496; A61K31/497; A61K45/06; A61K47/10; A61K47/12; A61K47/14; A61K9/0053; A61K9/0095; A61K9/08; A61P25/00; A61P25/14; A61P25/20 | August 03, 2022 |
| BR112014018657B1 | Grant | COMPOSTOS DE 1H-INDAZOL-3-CARBOXAMIDA | A61K31/454; A61K31/4545; A61K31/5377; A61P15/00; A61P21/02; A61P25/00; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P25/36; A61P29/00; A61P3/00; A61P3/04; A61P3/10; A61P35/00; A61P35/02; A61P43/00; C07D401/12; C07D401/14; C07D405/14; C07D413/14; C07D417/14 | August 02, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer